Live News Categoriesequity

JJ (JJ) News

Track canonical SquawkNews coverage tagged to JJ, JJ. This hub brings together deduplicated headlines about nasdaqgs, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol JJ Asset equity Sector Markets 90 days 1 Updated Aug 24, 2026, 10:40 PM UTC Open live news feed

M FDA approves J&J IMAAVY first WAIHA treatment for ages 12+ The FDA approves Johnson & Johnson’s IMAAVY as the first-ever treatment for warm autoimmune hemolytic anemia (WAIHA) in patients aged 12 and older. REGULATION | Aug 24, 2026, 10:40 PM UTC